ONE MISSION, INSPIRED BY PATIENTS: DEFEAT CANCER. Trademark
Trademark Overview
On Tuesday, February 9, 2021, a trademark application was filed for ONE MISSION, INSPIRED BY PATIENTS: DEFEAT CANCER. with the United States Patent and Trademark Office. The USPTO has given the ONE MISSION, INSPIRED BY PATIENTS: DEFEAT CANCER. trademark a serial number of 90521526. The federal status of this trademark filing is REGISTERED as of Tuesday, April 19, 2022. This trademark is owned by Deciphera Pharmaceuticals, LLC. The ONE MISSION, INSPIRED BY PATIENTS: DEFEAT CANCER. trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
providing medical information to patients relating to the management of hematological malignancies, cancer, auto-immune and inflammatory diseases and disorders; providing information regarding medical services and therapeutic properties of pharmaceutical products to patients relating to the management of hematological malignancies, cancer, autoimmune diseases and inflammatory diseases and disorders information
pharmaceutical research and development
General Information
| Serial Number | 90521526 |
| Word Mark | ONE MISSION, INSPIRED BY PATIENTS: DEFEAT CANCER. |
| Filing Date | Tuesday, February 9, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, April 19, 2022 |
| Registration Number | 6708585 |
| Registration Date | Tuesday, April 19, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 13, 2021 |
Trademark Statements
| Goods and Services | providing medical information to patients relating to the management of hematological malignancies, cancer, auto-immune and inflammatory diseases and disorders; providing information regarding medical services and therapeutic properties of pharmaceutical products to patients relating to the management of hematological malignancies, cancer, autoimmune diseases and inflammatory diseases and disorders information |
| Goods and Services | pharmaceutical research and development |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 14, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, December 31, 2020 |
| First Use In Commerce Date | Thursday, December 31, 2020 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 14, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | Thursday, December 31, 2020 |
| First Use In Commerce Date | Thursday, December 31, 2020 |
Trademark Owner History
| Party Name | Deciphera Pharmaceuticals, LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Waltham, MA 02451 |
| Party Name | Deciphera Pharmaceuticals, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Waltham, MA 02451 |
| Party Name | Deciphera Pharmaceuticals, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Waltham, MA 02451 |
Trademark Events
| Event Date | Event Description |
| Tuesday, April 19, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, March 17, 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Wednesday, March 16, 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Wednesday, March 16, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, March 15, 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| Thursday, March 3, 2022 | USE AMENDMENT FILED |
| Tuesday, March 15, 2022 | SOU EXTENSION 1 GRANTED |
| Thursday, March 3, 2022 | SOU EXTENSION 1 FILED |
| Monday, March 14, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, March 3, 2022 | TEAS EXTENSION RECEIVED |
| Thursday, March 3, 2022 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, September 7, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, July 13, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 13, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 23, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 8, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, June 8, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, June 8, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, June 8, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, June 8, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, May 31, 2021 | ASSIGNED TO EXAMINER |
| Friday, May 14, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, February 12, 2021 | NEW APPLICATION ENTERED IN TRAM |
